A comparison of the efficacy of levobupivacaine 0,125%, ropivacaine 0,125% and ropivacaine 0,2%, all combined with sufentanil 0.5 micrograms/mL, in patient-controlled epidural analgesia after hysterectomy under combined epidural and general anesthesia - levobupi 0,125%,ropiv 0,125% and 0,2%,with sufenta 0.5 microgr/mL, in PCEA

Academisch Medisch Centrum0 个研究点目标入组 63 人开始时间: 待定最近更新: 2024年5月13日

适应症

试验速览

暂无简介。

•*Female patient >18 years
•*ASA class I-III
•*Patients undergoing abdominal hysterectomy under combined epidural and general anesthesia
•*Written informed consent

•*Participation in a trial on investigational drugs within 3 months prior to the study
•*Known hypersensitivity to amide-type local anesthetics
•*Known hypersensitivity to opioids
•*Known history of severe cardiovascular, hepatic, renal, respiratory, endocrinological, haematological, neurological or psychiatric disease as judged by the investigator
•*Known history of peripheral neuropathies
•*Those receiving chronic analgesic therapy
•*Any contraindication for epidural analgesia (e.g. clotting disorders, history of lumbar surgery)
•*Inability to perform VAS score
•*Pregnancy or lactation
•*Any other reason which in the opinion of the investigator makes the patient unsuitable for participation in the study

发起方